发明名称 Antitumor agents having antimitotic and tubulin polymerization inhibiting action, comprising new or known 2-acyl-indole derivatives or aza analogs
摘要 The use of 2-acyl-indole derivatives (including aza analogs) (I) as antitumor agents is new. Most compounds (I) are new. The use of indole derivatives of formula (I) (including their stereoisomers, tautomers, mixtures and salts) is claimed in the preparation of medicaments for treating tumor diseases. R1 = H, alkylcarbonyl, alkyl, alkylamino-T-, dialkylamino-T- (where the dialkylamino group may form a ring, optionally containing one or more NH, N(alkyl), O or S members), arylalkyl or arylalkoxyalkyl; T = 1-4C alkyl; R2 = H, halo, CN or NO2, alkyl or alkoxy (both optionally substituted (os) by one or more halo), or alkenyl, alkynyl, cycloalkyl, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, ST, SOT, SO2T, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, aryl-T-, aryl-T-O-T-, alkylcarbonyl, alkoxycarbonyl or OH; A1-A4 = C-R3 or N; R3 = H, halo, CN or NO2, alkyl or alkoxy (both os by one or more halo); or alkenyl, alkynyl, cycloalkyl, alkoxy, 1-6C alkylenedioxy, alkoxycarbonyloxy, alkylcarbonyloxy, ST, SOT, SO2T, COOH, alkoxycarbonyl, CONH2, CONHT, CON(T)2, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, aryl-T-, aryl-T-O-T-, alkylcarbonyl or OH, or two adjacent R3 groups may be bonded, specifically as 1-6C alkylenedioxy; Y = aryl (preferably phenyl or naphthyl), 1-13C heteroaryl (containing 1-4 of N, NH, N(alkyl), O and/or S as ring members) or cycloalkyl, all os by one or more Q; Q = halo, CN, cyanoalkyl, OH, mono- or polyhydroxyalkyl, COOH, alkoxycarbonyl, CONH2, alkylcarbamoyl, CON(T)2, NO2, alkyl or alkoxy (both os by one or more halo), alkenyl, alkynyl, cycloalkyl, SH, alkylthio, alkylsulfinyl, alkylsulfonyl, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, arylalkyl, arylalkoxyalkyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, mono- or dialkylcarbonylamino, mono- or dialkoxycarbonylamino, N-alkylcarbonyl-N-alkylamino, N-alkoxycarbonyl-N-alkylamino, NHCHO or CHO; or two adjacent Q groups may be bonded, specifically as 1-6C alkylenedioxy, and X = O, S, NH or (H, OH); unless specified otherwise, alkyl moieties have 1-6C, alkenyl or alkynyl moieties 2-6C, cycloalkyl moieties 3-8C and aryl moieties 6-14C. Independent claims are included for the following: (a) new (I) (including their stereoisomers, tautomers, mixtures and salts), with the exception of (I; R1, R2 = H; A1, A3, A4 = CH; X = O or (if A2 = CH) CH(OH); Y = 3-carboxy-pyridin-4-yl; A2 = CH or C(OMe)), 2-cyclopropylcarbonyl-indole and 2-cyclohexylcarbonyl-indole; and (b) preparation of the new compounds (I).
申请公布号 DE10102629(A1) 申请公布日期 2002.07.25
申请号 DE20011002629 申请日期 2001.01.20
申请人 ASTA MEDICA AG 发明人 BECKERS, THOMAS;BAASNER, SILKE;KLENNER, THOMAS;MAHBOOBI, SIAVOSH;PONGRATZ, HERWIG;FRIESER, MARKUS;HUFSKY, HARALD;HOCKEMEYER, JOERG;FIEBIG, HEINZ-HERBERT;BURGER, ANGELIKA;BOEHMER, FRANK-D.
分类号 A61K31/404;A61K31/437;A61K31/4439;A61K31/4709;(IPC1-7):C07D209/12;A61K31/519;A61K31/53;C07D215/14;C07D401/06;C07D471/04;C07D487/04 主分类号 A61K31/404
代理机构 代理人
主权项
地址